All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network.

The MPN Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

BCL-2 inhibitors

BCL-2 inhibitors

Bcl-2 is a pro-survival oncogene that promotes leukemogenesis by blocking programmed cell death. Therefore, agents designed to disrupt anti-apoptotic signaling pathways are considered for treatment of hematological malignancies, including Bcl-2 inhibitors like venetoclax. Another subfamily of ‘BH3-only’ proteins induce apoptosis by binding to BCL-2. Agonist for pro-apoptotic proteins, like ‘BH3-only’ proteins, are in development.

|||